A surprise brain cancer diagnosis left Violet the French bulldog’s family reeling. A clinical trial testing a new tumor treatment seeks to bring patients like her more quality months with their families.
As shelter-in-place mandates lessen, societies may be able to reopen parts of their economies while still curbing overall disease spread by limiting interactions related to increased disease.
Meggan Craft, PhD, associate professor in the Department of Veterinary Population Medicine is collaborating with Eva Enns, PhD, associate professor in the Division of Health Policy and Management in the School of Public Health, to create a model of how the novel coronavirus moves through an individual’s network.
Proteins of highly pathogenic viruses, such as SARS-CoV-2 that causes COVID-19 disease, play a critical role in the body’s immune response to infection, sometimes causing overt inflammation and tissue damage.
Human pulmonary epithelial cells, which serve many important functions in human lungs, express two key enzymes, ACE2 and TMPRSS2, that help SARS-CoV-2, the virus that causes COVID-19, enter human p
Transmission models of COVID-19 are used by policymakers and hospital leaders to inform disease prevention and mitigation activities and prepare for case surges.
Social distancing can help deter some of COVID-19’s spread, but the development of a vaccine is the only surefire way to combat this devastating disease.
